In the news

Many cancer drugs fail not because of cancer cells, but their surroundings

Read article from our CEO, Duleek Ranatunga, following this link here.

See what we have in the works

Our drug discovery pipeline is focused on a range of indications from breast to lung cancer. Explore more about our pipeline.